---
blocking_issues_count: 2
warnings_count: 8
tasklist_ready: false
validation_mode: adversarial
validation_agents: 'opus-architect, haiku-analyzer'
---

## Agreement Table

| Finding ID | Description | Agent A (opus) | Agent B (haiku) | Agreement Category |
|---|---|---|---|---|
| F-01 | Timeline/effort contradiction (11 vs 10 sprints) | FOUND (BLOCKING) | FOUND (INFO) | CONFLICT |
| F-02 | `interleave_ratio` frontmatter type/schema mismatch | FOUND (INFO) | FOUND (BLOCKING+WARNING) | CONFLICT |
| F-03 | NFR-001 requirement-to-phase allocation mismatch | FOUND (WARNING) | -- | ONLY_A |
| F-04 | Deliverable traceability gaps (P1.3, P2.4) | FOUND (WARNING, P1.3 only) | FOUND (BLOCKING, P1.3+P2.4) | CONFLICT |
| F-05 | P4.1 compound deliverable (3 outputs) | FOUND (WARNING) | -- | ONLY_A |
| F-06 | P5.5 compound deliverable (4 activities) | FOUND (WARNING) | -- | ONLY_A |
| F-07 | P5.6 compound deliverable (2 governance domains) | FOUND (WARNING) | -- | ONLY_A |
| F-08 | Phase 3 numbering inconsistency (Sprint vs P3.x) | FOUND (INFO) | -- | ONLY_A |
| F-09 | Phase 3 list style inconsistency (numbered vs bullet) | FOUND (INFO) | -- | ONLY_A |
| F-10 | P0.3 compound deliverable (5 outputs) | -- | FOUND (WARNING) | ONLY_B |
| F-11 | P2.5 compound deliverable (schema + rollout) | -- | FOUND (WARNING) | ONLY_B |
| F-12 | P4.3 compound deliverable (6 testing outputs) | -- | FOUND (WARNING) | ONLY_B |

## Consolidated Findings

### BLOCKING

- **[F-01] [BLOCKING] Structure: Internal timeline/effort contradiction between Executive Summary and Timeline Summary**
  - Location: `roadmap.md:Executive Summary` vs `roadmap.md:Timeline Summary`
  - Evidence: Executive Summary states 11 sprints / ~22 calendar weeks / 39-60 working days. Timeline Summary states 10 sprints / ~20 calendar weeks / 37-57 working days. Per-phase breakdowns corroborate the Timeline Summary figures (3-5 + 4-6 + 9-14 + 10-15 + 7-10 + 4-7 = 37-57).
  - Resolution: **CONFLICT resolved → BLOCKING.** Agent A classified this as BLOCKING with detailed numeric evidence; Agent B classified it as INFO. The contradiction involves authoritative scheduling metadata that downstream tooling (sc:tasklist) would consume directly. Inconsistent sprint counts and effort ranges would produce conflicting task schedules. Agent A's severity is correct.
  - Fix guidance: Update Executive Summary to match Timeline Summary: 10 sprints, ~20 calendar weeks, 37-57 working days.

- **[F-04] [BLOCKING] Traceability: Multiple deliverables lack explicit requirement citations**
  - Location: `roadmap.md:P1.3`, `roadmap.md:P2.4`, `roadmap.md:83-88`, `roadmap.md:133-141`
  - Evidence: P1.3 (Minimal Confidence Metadata Tags) cites only success criteria SC-006/SC-015 but no FR/NFR. P2.4 (Adversarial Test Fixtures) cites only SC-007 and no FR/NFR. Phase 1's requirement list omits FR-006 which P1.3 partially implements.
  - Resolution: **CONFLICT resolved → BLOCKING.** Agent A identified P1.3 as a WARNING-level gap. Agent B identified P1.3 and P2.4 as a BLOCKING-level gap, noting the validation requirement expects every deliverable to trace to a requirement. The broader scope (multiple deliverables affected) and the validation spec's explicit traceability requirement justify BLOCKING.
  - Fix guidance: Add explicit requirement mappings to P1.3 ("FR-006 partial") and P2.4. Consider adding a requirement-to-deliverable trace table covering all P-items.

### WARNING

- **[F-02] [WARNING] Schema: `interleave_ratio` frontmatter type mismatch**
  - Location: `test-strategy.md:2-3`
  - Evidence: Frontmatter stores `interleave_ratio: '1:2'` (a string ratio notation). The validation formula produces a numeric value (`6/6 = 1.0`). Both agents agree the computed ratio is 1.0 and within range. Both agents agree interleaving is healthy and not back-loaded.
  - Resolution: **CONFLICT resolved → WARNING.** Agent A classified this as INFO ("distinct metrics, no action required"). Agent B classified the type issue as BLOCKING and the misleading value as WARNING. The field name matches the validation formula's output field, so the value should be consistent, but it does not block tasklist generation since the computed ratio (1.0) is valid and test distribution is healthy. WARNING is the appropriate severity.
  - Fix guidance: Replace `interleave_ratio: '1:2'` with `interleave_ratio: 1.0` in frontmatter. Describe the "1 test cycle per 2 implementation tasks" cadence in body text if desired.

- **[F-03] [WARNING] Cross-file consistency: NFR-001 requirement-to-phase allocation mismatch** *(ONLY_A)*
  - Location: `roadmap.md:Phase 1` requirements vs `test-strategy.md:Milestone B`
  - Evidence: Roadmap allocates NFR-001 to Phase 1, but Phase 1 introduces no semantic validation gates. Test-strategy validates NFR-001 at Milestone B (Phase 2). NFR-001 does not appear in Phase 2's requirements list.
  - Fix guidance: Move NFR-001 from Phase 1 to Phase 2 requirements, or add NFR-001 acceptance criteria to Phase 1 in the test-strategy.

- **[F-05] [WARNING] Decomposition: P4.1 is compound (3 distinct pipeline stages)** *(ONLY_A)*
  - Location: `roadmap.md:P4.1 Retrospective-to-Spec Pipeline`
  - Evidence: Three separate actions: (1) extraction, (2) spec-constraint conversion, (3) next-spec injection.
  - Fix guidance: Consider splitting into P4.1a/b/c or accept sc:tasklist auto-decomposition.

- **[F-06] [WARNING] Decomposition: P5.5 is compound (4 distinct activities)** *(ONLY_A)*
  - Location: `roadmap.md:P5.5 Backward Compatibility and Migration`
  - Evidence: Bundles regression testing, false regression confirmation, fallback mode implementation, and migration timeline definition.
  - Fix guidance: Split into P5.5a (regression validation) and P5.5b (fallback mode + migration path).

- **[F-07] [WARNING] Decomposition: P5.6 is compound (2 governance domains)** *(ONLY_A)*
  - Location: `roadmap.md:P5.6 Governance Formalization`
  - Evidence: Combines adversarial ledger governance with evidence trail audit formalization (NFR-008). Different stakeholders.
  - Fix guidance: Split into P5.6a (ledger governance) and P5.6b (evidence trail audit).

- **[F-10] [WARNING] Decomposition: P0.3 is compound (5 distinct outputs)** *(ONLY_B)*
  - Location: `roadmap.md:51-58`
  - Evidence: Bundles seam mapping, validator classification, architecture evaluation, decision artifact creation, and conditional branch handling.
  - Fix guidance: Split into seam inventory, validator taxonomy, architecture assessment memo, and go/no-go decision handling.

- **[F-11] [WARNING] Decomposition: P2.5 is compound (schema + rollout)** *(ONLY_B)*
  - Location: `roadmap.md:143-156`
  - Evidence: Combines YAML schema definition, artifact attachment to all pipeline outputs, and extension of Phase 1 tags into machine-readable framework.
  - Fix guidance: Split into schema definition, artifact attachment work, and validation/tooling integration.

- **[F-12] [WARNING] Decomposition: P4.3 is compound (6 testing outputs)** *(ONLY_B)*
  - Location: `roadmap.md:293-303`
  - Evidence: Bundles harness creation, three property suites, mock-test coexistence, non-determinism handling, and defect/environment separation.
  - Fix guidance: Break into harness setup, property test suites, coexistence/regression work, and stability-tolerance handling.

### INFO

- **[F-08] [INFO] Structure: Phase 3 uses Sprint-based numbering instead of P3.x** *(ONLY_A)*
  - Location: `roadmap.md:Phase 3 Sprint headings`
  - Evidence: All other phases use P*.* numbering; Phase 3 uses "Sprint 1/2/3". Internally consistent but differs from document convention.
  - Fix guidance: No action required unless sc:tasklist parser expects uniform ID schemes.

- **[F-09] [INFO] Parseability: Phase 3 uses numbered lists while other phases use bullets** *(ONLY_A)*
  - Location: `roadmap.md:Phase 3 Sprint 1-3`
  - Evidence: Formatting inconsistency (numbered vs bullet lists). Both valid markdown.
  - Fix guidance: Normalize if sc:tasklist splitter is sensitive to list type.

## Summary

| Severity | Count |
|----------|-------|
| BLOCKING | 2 |
| WARNING | 8 |
| INFO | 2 |
| **Total** | **12** |

### Agreement Statistics

| Category | Count | Findings |
|----------|-------|----------|
| BOTH_AGREE | 0 | -- |
| CONFLICT (resolved) | 3 | F-01, F-02, F-04 |
| ONLY_A | 6 | F-03, F-05, F-06, F-07, F-08, F-09 |
| ONLY_B | 3 | F-10, F-11, F-12 |

### Conflict Resolutions

- **F-01** (timeline contradiction): A=BLOCKING, B=INFO → **BLOCKING**. Scheduling metadata inconsistency directly impacts downstream tooling.
- **F-02** (interleave_ratio type): A=INFO, B=BLOCKING → **WARNING**. Type mismatch should be fixed but does not block tasklist generation since computed ratio is valid.
- **F-04** (traceability gaps): A=WARNING (1 item), B=BLOCKING (2 items) → **BLOCKING**. Multiple deliverables affected; validation spec requires complete traceability.

### Overall Assessment

**Not ready for tasklist generation.** Two blocking issues must be resolved:

1. **Timeline contradiction** — straightforward fix: align Executive Summary to Timeline Summary's corroborated figures (10 sprints, ~20 weeks, 37-57 days).
2. **Traceability gaps** — add explicit FR/NFR citations to P1.3 and P2.4; consider a requirement-to-deliverable trace table.

The 8 warnings are predominantly decomposition concerns (6 of 8) where compound deliverables should be split for clean sc:tasklist processing. The remaining 2 warnings address cross-file consistency (NFR-001 phase allocation) and schema type (interleave_ratio frontmatter). All warnings have clear, low-effort fixes.

The roadmap is otherwise well-structured: heading hierarchy is valid, milestone DAG is acyclic, interleave ratio computes to 1.0 (healthy distribution), and content is readily parseable.

## Interleave Ratio

Both agents independently computed the same result:

- **Formula**: `unique_phases_with_deliverables / total_phases = 6 / 6 = 1.0`
- **Assessment**: Within acceptable range [0.1, 1.0]. Test activities are not back-loaded; every phase contains both implementation and validation work.
